Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2024-2030

Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2024-2030

The Biological Sample Handling Market size was estimated at USD 18.62 billion in 2023 and expected to reach USD 19.85 billion in 2024, at a CAGR 6.47% to reach USD 28.88 billion by 2030.

Biological sample handling refers to collecting, storing, processing, and transporting biological materials, such as blood, tissue, saliva, or any other organismal specimen, in a way that preserves the integrity and minimizes contamination or degradation of the sample. This process is crucial for ensuring the reliability of biological research, clinical diagnostics, and therapeutic interventions. It encompasses a wide range of protocols and procedures tailored to the specific requirements of the biological material, including temperature control, contamination prevention, and legal and ethical compliance regarding sample collection and use. An increase in research and development (R&D) activities, especially in genomics, proteomics, and personalized medicine, drives the demand for sophisticated sample-handling solutions to ensure sample integrity and reliability. However, the strict regulations associated with biological sample handling are a significant challenge the key players face. Companies adhere to government regulations to remain sustainable and agile within the global space. Moreover, technological advancements in automation and cryopreservation have revolutionized the handling of biological samples. Automated systems reduce human error and increase throughput, while advances in cryopreservation techniques have extended the viability of samples, thereby supporting longer-term studies.

Regional Insights

In the Americas, biological sample handling is highly regulated, strongly emphasizing compliance with FDA regulations and guidelines. Recent patents have focused on improving the accuracy and efficiency of sample processing. Investments in biobanking and personalized medicine have driven the demand for advanced sample-handling solutions in this region. Customers in America prioritize reliability and quality, with a growing interest in automation and integrated systems. On the other hand, in the EMEA, the regulatory environment is stringent, with a focus on data protection and patient privacy impacting sample handling practices. Investments in biobanks and translational research are widespread in the region. Moreover, the Asia-Pacific region is witnessing a dynamic shift in the biological sample handling market, characterized by significant growth due to rising investments in biobanking, an expanding biopharmaceutical sector, and an increasing emphasis on research and development activities. The proliferation of chronic diseases and the urgent need for personalized medicine are significant drivers propelling advancements in biological sample-handling techniques.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biological Sample Handling Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing need for fluid sample management and handling in personalized healthcare
• Growing demand from genomics and proteomics and the rise in biobanking practices
• Exponential growth of biomarker analysis and the need for sophisticated sample handling

Market Restraints

• Strict regulations associated with biological sample handling

Market Opportunities

• Increasing investment in life sciences R&D activities
• Technological advancements and innovations in sample handling

Market Challenges

• Complexity associated with operations and need for specific handling protocols

Market Segmentation Analysis

• Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
• End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biological Sample Handling Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biological Sample Handling Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

MedLife to Transport Lab Samples with Drones

MedLife partnered with Skyy Network to revolutionize the transportation of biological laboratory samples via drones. This innovative approach not only positions MedLife as the inaugural private medical operator in the region to harness drone technology for the movement of laboratory samples but also ranks it among the select few medical entities in Europe adept at conducting medium to long-distance biological sample transportation. This enhancement signals a significant leap towards enhancing healthcare logistics, demonstrating MedLife's commitment to leveraging technology for improved medical services.

BioLizard and Parean Biotechnologies Announce Partnership

Parean Biotechnologies, a renowned immune omics analysis, partnered strategically with BioLizard, a multi-national player in bioinformatics, data analytics, and data management. This partnership signifies a milestone in the life sciences industry by combining Parean Biotechnologies' expertise in decoding the immune system through a comprehensive integration of wet lab techniques and data science with BioLizard's exceptional capabilities in custom advanced analytics and digital transformation services. This symbiotic partnership is poised to enhance the offerings of both entities, leveraging their respective strengths to provide unparalleled services to their bio-pharma clientele within the realm of biological sample handling.

MolGen Acquires Synchron Lab Automation

MolGen strategically enhanced its portfolio by acquiring Synchron Instrumenten BV, known as Synchron Lab Automation. This move significantly broadens MolGen's capabilities in developing advanced automation solutions, particularly DNA/RNA purification, library preparation, and NGS setup, bolstering its reagent business. Leveraging Synchron's expertise in custom liquid handling platforms and its rapid prototyping capabilities, MolGen is poised to extend its automation offerings further.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biological Sample Handling Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
• Cellular & Genetic Material
• Saliva Samples
• Stool Samples
• Urine Samples
• Product
• Blood Collection Kits
• Swabs
• Nasal Swabs
• Nasopharyngeal Swabs
• Oropharyngeal Swabs
• Viral Transport Media
• End-Use
• Diagnostic Centers
• Homecare
• Hospitals & Clinics
• Application
• Diagnostics
• Research

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year